Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Office-based treatment for opioid dependence: reaching new patient populations.

Literature DB >> 11481150

Office-based treatment for opioid dependence: reaching new patient populations.

D A Fiellin¹, R A Rosenheck, T R Kosten.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：
Buprenorphine

Year: 2001 PMID： 11481150 DOI： 10.1176/appi.ajp.158.8.1200

Source DB: PubMed Journal: Am J Psychiatry ISSN： 0002-953X Impact factor: 18.112

Keyword Cloud
Cited

× No keyword cloud information.

19 in total

1. Provision of ancillary medications during buprenorphine detoxification does not improve treatment outcomes.

Authors: Maureen Hillhouse; Catherine P Domier; David Chim; Walter Ling
Journal: J Addict Dis Date: 2010-01

2. To Be Free and Normal: Addiction, Governance, and the Therapeutics of Buprenorphine.

Authors: Shana Harris
Journal: Med Anthropol Q Date: 2015-08-18

3. Initiation of buprenorphine during incarceration and retention in treatment upon release.

Authors: Nickolas Zaller; Michelle McKenzie; Peter D Friedmann; Traci C Green; Samuel McGowan; Josiah D Rich
Journal: J Subst Abuse Treat Date: 2013-03-27

4. Treatment Outcome Comparison Between Telepsychiatry and Face-to-face Buprenorphine Medication-assisted Treatment for Opioid Use Disorder: A 2-Year Retrospective Data Analysis.

Authors: Wanhong Zheng; Michael Nickasch; Laura Lander; Sijin Wen; Minchan Xiao; Patrick Marshalek; Ebony Dix; Carl Sullivan
Journal: J Addict Med Date: 2017 Mar/Apr Impact factor: 3.702

5. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.

Authors: Frederick L Altice; R Douglas Bruce; Gregory M Lucas; Paula J Lum; P Todd Korthuis; Timothy P Flanigan; Chinazo O Cunningham; Lynn E Sullivan; Pamela Vergara-Rodriguez; David A Fiellin; Adan Cajina; Michael Botsko; Vijay Nandi; Marc N Gourevitch; Ruth Finkelstein
Journal: J Acquir Immune Defic Syndr Date: 2011-03-01 Impact factor: 3.731

Office-based treatment for opioid dependence: reaching new patient populations.

1. Provision of ancillary medications during buprenorphine detoxification does not improve treatment outcomes.

2. To Be Free and Normal: Addiction, Governance, and the Therapeutics of Buprenorphine.

3. Initiation of buprenorphine during incarceration and retention in treatment upon release.

4. Treatment Outcome Comparison Between Telepsychiatry and Face-to-face Buprenorphine Medication-assisted Treatment for Opioid Use Disorder: A 2-Year Retrospective Data Analysis.

5. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.

6. Participant characteristics and buprenorphine dose.

7. Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings.

8. Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy.

9. Buprenorphine for opioid dependence.

10. Comparison of behavioral treatment conditions in buprenorphine maintenance.